ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.1950
0.00 (0.00%)
At close: Jun 15, 2026
ZyVersa Therapeutics Employees
ZyVersa Therapeutics had 6 employees as of December 31, 2025. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$4,081,472
Market Cap
1.58M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6 | -1 | -14.29% |
| Dec 31, 2024 | 7 | 0 | - |
| Dec 31, 2023 | 7 | 0 | - |
| Dec 31, 2022 | 7 | - | - |
| Sep 30, 2022 | 6 | - | - |
| Jun 30, 2022 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| International Stem Cell | 33 |
| Clearside Biomedical | 32 |
| Iterum Therapeutics | 9 |
| AXIM Biotechnologies | 7 |
| Abpro Holdings | 3 |
| Hepion Pharmaceuticals | 2 |
| Bio-Path Holdings | 1 |
ZyVersa Therapeutics News
- 4 weeks ago - ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - ZyVersa Therapeutics Quarterly report: Q1 2026 - Filings
- 4 weeks ago - ZyVersa Therapeutics Earnings release: Q1 2026 - Filings
- 2 months ago - ZyVersa Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - ZyVersa Therapeutics Annual report: Q4 2025 - Filings
- 2 months ago - ZyVersa Therapeutics Earnings release: Q4 2025 - Filings
- 7 months ago - ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 7 months ago - ZyVersa Therapeutics Earnings release: Q3 2025 - Filings